glp 1 agonists and anesthesia The Impact of GLP-1 Receptor on Sedation Updated guidance for patients using

After a review of currently available data, the US Food and Drug Administration (FDA) and the European Medicines Agency agreed that there was insufficient evidence to confirm an increased risk of pancreatitis and pancreatic cancer with use of GLP-1-based therapies [104]

At present, there isnt enough data to confirm whether GLP-1 receptor agonists pass into breast milk in humans, or how they might affect a baby if they do

Graphical abstract Suspected clinical impacts of GLP-1RAs, SGLT2is, and finerenone oncardiovascular and kidney outcomes

The bottom line: you can get a prescription, fill it, and start treatment today

injections with a dose of 100 nmol kg 1 of the experimental compounds